Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone

Journal of Rheumatology

Volumn 28, Issue 4, 2001, Pages 814-824

  Pelletier, J P ^a   Lajeunesse, D ^a   Reboul, P ^a   Mineau, F ^a   Fernandes, J C ^a   Sabouret, P ^a   Martel Pelletier, J ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

Diacerein; Osteoarthritis; Osteoblasts; Remodeling factors; Subchondral bone

Indexed keywords

ALKALINE PHOSPHATASE; CYCLIC AMP; CYCLOOXYGENASE 2; DIACETYLRHEIN; INTERLEUKIN 6; OSTEOCALCIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTAGLANDIN E2; RHEIN; SOMATOMEDIN C; UROKINASE;

ARTICLE; BONE REMODELING; HUMAN; OSTEOARTHRITIS; OSTEOBLAST; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTHRAQUINONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE AND BONES; BONE REMODELING; CELLS, CULTURED; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; OSTEOBLASTS;

EID: 0035086123     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Osteoarthritis in cynomolgus macaques. III: Effects of age, gender, and subchondral bone thickness on the severity of disease
2. Subchondral bone in osteoarthritis
3. Role of subchondral bone in the initiation and progression of cartilage damage
4. A longitudinal study of subchondral plate and trabecular bone in cruciate-deficient dogs with osteoarthritis followed up for 54 months
5. Preliminary report: Increased porosity of the subchondral plate in an accelerated canine model of osteoarthritis
6. Osteoarthritic changes in canine articular cartilage, subchondral bone, and synovium fifty-four months after transection of the anterior cruciate ligament
7. The importance of subchondral bone in osteoarthrosis
8. Carprofen simultaneously reduces the progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis
9. IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis
10. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: Possible role in subchondral bone sclerosis
11. Subchondral bone morphological and biochemical alterations in osteoarthritis
12. Biochemical evidence for altered subchondral bone collagen metabolism in osteoarthritis of the hip
13. Abnormal cancellous bone collagen metabolism in osteoarthritis
14. Alteration of cartilage metabolism by cells from osteoarthritic bone
15. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions
16. Fractal properties of subchondral cancellous bone in severe osteoarthritis of the hip
17. Osteoarthritic osteoblasts show variable levels of cytokine production despite similar phenotypic expression
18. A non-steroidal antiinflammatory drug that stimulates prostaglandin release
19. The influence of rhein on the biosynthesis of prostaglandin-like substances in vitro
20. Diacerein and rhein reduce the interleukin-1 beta stimulated inducible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes
21. Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures
22. Diacerein and rhein reduce the ICE-induced IL-1β and IL-18 activation in human osteoarthritic cartilage
23. In vitro effects of diacerein and rhein on interleukin-1 and tumor necrosis factor-α systems in human osteoarthritic synovium and chondrocytes
24. Inhibition par la rheine de la production des nitrosothiols des chondrocytes humains arthrosiques en culture
25. Etude de la diacetylrheine sur un modele post-contusif d'arthrose experimentale chez le lapin
26. Effects of diacerein in an accelerated canine model of osteoarthritis
27. Effects of diacerein on granuloma induced cartilage breakdown in the mouse
28. Diacerein treatment reduces the severity of osteoarthritis in the canine cruciate-deficiency model of osteoarthritis
29. Efficacy and tolerability of diacerein in the treatment of osteoarthritis
30. Diacerein in the treatment of osteoarthritis of the hip
31. Efficacy and safety of diacerein in osteoarthritis of the knee: A double blind placebo controlled trial
32. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee
33. Measurement of protein using bicinchoninic acid
34. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
35. Efficacité et.tolérance de la diacérheine dans le traitement de la gonarthrose et de la coxarthrose
36. Evaluation des effets de la diacereine dans un modele ovin d'arthrose
37. Collagen and non-collagenous protein content (osteocalcin, sialoprotein, proteoglycan) in the iliac crest bone and serum osteocalcin in women with and without hand osteoarthritis
38. Alterations of the mineralization profile and osteocalcin concentrations in osteoarthritic cortical iliac crest bone
39. Increased bone formation in osteocalcin-deficient mice
40. Composition and mechanical properties of cancellous bone from the femoral head of patients with osteoporosis or osteoarthritis
41. Parathyroid hormone (PTH) and PTH-like protein stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis
42. Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption
43. Stimulation of bone resorption by various prostaglandins in organ culture
44. 2 on bone formation in cultured fetal rat calvariae: Interaction with cortisol
45. 2 prevents bone loss and adds extra bone to immobilized distal femoral metaphysis in female rats
46. 2 in fetal rat osteoblasts: Role of protein kinase A signaling pathway
47. 2 stimulates the production of interleukin-6 by neonatal mouse parietal bones
48. 2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone